Imminent Catalysts Should Keep Investor Interest Alive for These 3 …

Published February 4, 2013

Imminent Catalysts Should Keep Investor Interest Alive For These 3 …

Filed under: residential drug treatment programs

Recent news now centers around OrbeShield®, oral beclomethasone 17,21-dipropionate, or oral BDP, being developed to treat gastrointestinal (GI) inflammation in gastrointestinal acute radiation syndrome (GI ARS). The company's shares began their recent …
Read more on Seeking Alpha

World Cancer Day: Are we killing cancer?

Filed under: residential drug treatment programs

A report by the King's Fund in 2011 claimed that the rate of overall improvement in cancer survival accelerated between 2004 and 2007, possibly as a result of the NHS Cancer Plan, published in 2000, under Prof Sir Mike Richards, National Clinical …
Read more on Telegraph.co.uk

Truck driver charged over school bus crash

Filed under: residential drug treatment programs

After a lengthy investigation, the 34-year-old truck driver from Queensland has been charged with three offences that include dangerous driving occasioning death and drive motor vehicle with prescribed illicit drug present in blood or urine. The truck …
Read more on Sydney Morning Herald

Shambhala death confirmed as drug overdose

Filed under: residential drug treatment programs

… not witnessed.” Fleischacker's death was the first in Shambhala's 15-year history. He grew up in Stettler, Alberta and worked at a sheet metal company in Victoria. He was in trouble with the law a few years ago for drug possession and underwent …
Read more on Nelson Star